IRVING, Texas, Feb. 3 /PRNewswire-FirstCall/ -- RBC Life Sciences (OTC Bulletin Board: RBCL), a provider of proprietary nutritional supplements, wound care and pain management products, has donated 100,000 sterile dressings to help the tens of thousands of Haitian earthquake victims suffering from burns, abrasions, deep wounds and similar injuries.
"Cleaning and properly treating wounds is critical following such a devastating tragedy," said RBC Life Sciences President and CEO John W. Price. "Infected or exposed wounds can trigger life-threatening problems. We're happy to join the global wound care community in providing the care that so many of the survivors need."
Under its MPM Medical brand, RBC Life Sciences specializes in wound care and pain management products. MPM Medical donated 100,000 of its Multilayered Composite Dressings to the Red Cross to be distributed by healthcare professionals on the island nation. Sterile wound care dressings are among the supplies needed to treat the most prevalent wounds suffered during the earthquake.
About RBC Life Sciences
RBC Life Sciences develops, manufactures and markets high quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the RBC Life Sciences Web site at www.rbclifesciences.com and the MPM Medical Web site at www.mpmmedicalinc.com
The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
SOURCE RBC Life Sciences, Inc.
|SOURCE RBC Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved